Global OTC Market is Growing At A Fair Pace and Is Estimated to Reach $ XX Billion With A CAGR Of XX% During 2018-2024.

envision
envision
The report "Global Over-the-Counter (OTC) Drugs Market”: - By Product (Cough and Cold, Analgesics, Vitamin, Minerals, and Supplements, Dermatological Products, Gastrointestinal Products, Weight Loss/Dietary Products, ophthalmic Products, and Others); By Geography - Forecast (2018-2024). Envision Intelligence estimates that over the counter industry is projected to reach with $XX Billion by the end of 2024 with a CAGR of XX% from $XX Billion in 2017. Over-the-Counter (OTC) drugs, also known as non-prescription drugs are safe and effective for use, without the supervision of the doctor or physician. These drugs are used for relieving aches, pains, and itches. These drugs help consumers in self-diagnosing, self-treating, and self-managing acute problems, like headache, arthritis pain, sprains, and other minor joint and muscle problems.They provide affordable treatment and also help to decrease the workload of physicians. These drugs help to build a diverse product portfolio for healthcare business of pharmaceutical companies also it helps to extend product range for consumer brands of consumer goods companies. Download Free Sample Brochure at:https://www.envisioninteligence.com/industry-report/global-over-the-counter-otc-drugs-market/ Cough and Cold segment is expected to have largest market size during the forecast period Globally, cough and cold product category prevailed the over the counter drug market in 2018, owing to their abounding use in developed nations such as United States, Germany, Japan, etc. The OTC drug market size is expected to grow because of growing healthcare costs and increasing older population demands for the need of better accessibility and affordability of healthcare services. In 2017, the overall OTC sales data were worth US $287.7 billion. North America held supremacy in terms of revenue in OTC Market during the forecast period North America holds the largest share in the OTC industry due to increasing investment from the government to develop OTC drugs for various diseases. Europe and North America are major shareholders of the global OTC market size with positive OTC market trends emerging from Asia-Pacific Regions such as from countries like China and India. The huge investment to develop OTC drugs for treating chronic diseases such as diabetes, hypertension to capture a major share is a major trend among the OTC manufacturers. Key players in the market include: GlaxoSmithKline Pfizer Novartis Reddy's Laboratories Piramal Takeda